AU689168B2 - Non-hydroquinone photographic developer composition and processing method - Google Patents
Non-hydroquinone photographic developer composition and processing method Download PDFInfo
- Publication number
- AU689168B2 AU689168B2 AU10922/95A AU1092295A AU689168B2 AU 689168 B2 AU689168 B2 AU 689168B2 AU 10922/95 A AU10922/95 A AU 10922/95A AU 1092295 A AU1092295 A AU 1092295A AU 689168 B2 AU689168 B2 AU 689168B2
- Authority
- AU
- Australia
- Prior art keywords
- acid
- ascorbic acid
- amount
- alkali metal
- developer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- G—PHYSICS
- G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
- G03C—PHOTOSENSITIVE MATERIALS FOR PHOTOGRAPHIC PURPOSES; PHOTOGRAPHIC PROCESSES, e.g. CINE, X-RAY, COLOUR, STEREO-PHOTOGRAPHIC PROCESSES; AUXILIARY PROCESSES IN PHOTOGRAPHY
- G03C5/00—Photographic processes or agents therefor; Regeneration of such processing agents
- G03C5/26—Processes using silver-salt-containing photosensitive materials or agents therefor
- G03C5/29—Development processes or agents therefor
- G03C5/30—Developers
-
- G—PHYSICS
- G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
- G03C—PHOTOSENSITIVE MATERIALS FOR PHOTOGRAPHIC PURPOSES; PHOTOGRAPHIC PROCESSES, e.g. CINE, X-RAY, COLOUR, STEREO-PHOTOGRAPHIC PROCESSES; AUXILIARY PROCESSES IN PHOTOGRAPHY
- G03C1/00—Photosensitive materials
- G03C1/005—Silver halide emulsions; Preparation thereof; Physical treatment thereof; Incorporation of additives therein
- G03C1/06—Silver halide emulsions; Preparation thereof; Physical treatment thereof; Incorporation of additives therein with non-macromolecular additives
- G03C1/061—Hydrazine compounds
-
- G—PHYSICS
- G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
- G03C—PHOTOSENSITIVE MATERIALS FOR PHOTOGRAPHIC PURPOSES; PHOTOGRAPHIC PROCESSES, e.g. CINE, X-RAY, COLOUR, STEREO-PHOTOGRAPHIC PROCESSES; AUXILIARY PROCESSES IN PHOTOGRAPHY
- G03C2200/00—Details
- G03C2200/48—Polyoxyethylene
-
- G—PHYSICS
- G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
- G03C—PHOTOSENSITIVE MATERIALS FOR PHOTOGRAPHIC PURPOSES; PHOTOGRAPHIC PROCESSES, e.g. CINE, X-RAY, COLOUR, STEREO-PHOTOGRAPHIC PROCESSES; AUXILIARY PROCESSES IN PHOTOGRAPHY
- G03C7/00—Multicolour photographic processes or agents therefor; Regeneration of such processing agents; Photosensitive materials for multicolour processes
- G03C7/30—Colour processes using colour-coupling substances; Materials therefor; Preparing or processing such materials
- G03C7/32—Colour coupling substances
- G03C7/36—Couplers containing compounds with active methylene groups
- G03C7/38—Couplers containing compounds with active methylene groups in rings
- G03C7/384—Couplers containing compounds with active methylene groups in rings in pyrazolone rings
Landscapes
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Silver Salt Photography Or Processing Solution Therefor (AREA)
Abstract
A non-hydroquinone photographic developer composition comprising:(a) a developer selected from the group consisting of ascorbic acid and sugar-type derivatives thereof, or alkali metal salts and mixtures thereof, in an amount of 0.1 to 0.4 mol/liter (mol/l);(b) an effective amount of an auxiliary developing agent comprising a 3-pyrazolidone compound, an aminophenol or a mixture thereof;(c) an alkali metal sulfite in an amount less than or equal to 0.32 mol/l;(d) an alkali metal carbonate in an amount of 0.1 to 0.4 mol/l;(e) an alkali metal hydroxide in an amount of from 0.08 to 2.0 mols/l;(f) with the developer composition having a pH of 11.8 or higher at 25° C.; and(g) the developer composition does not contain an alkanolamine or contains an alkanolamine in an amount of less than 5 g/l; where the developer composition is useful for processing standard rapid access films while showing an especially advantageous effect in the processing of silver halide emulsions containing a hydrazine compound to achieve lith quality, and high dot quality in a stable development solution.
Description
,WO 95/00881 PCT/US94/06353 "NON-HYDROQUINONE PHOTOGRAPHIC DEVELOPER COMPOSITION AND PROCESSING METHOD FIELD OF THE INVENTION This invention relates to a non-hydroquinone developer composition and its method of usage in development of photographic elements. More specifically, this invention relates to a non-hydroquinone developer composition which is particularly useful in the development of various types of photographic black-and-white photographic elements to assuredly achieve a lith quality development without the need for the presence of toxic hydroquinone. Even more particularly, the photographic developing composition of the present invention is advantageously used to develop internally boosted silver halide emulsions containing a hydrazine compound functioning as a nucleating agent.
BACKGROUND OF THE INVENTION Hi c-".trast development of black-and-white lithographic films has been a ji. ished for a number of years using special developers which are referred to in the field as "lith" developers. As explained in U.S. Patent No. 4,988,604, in conventional "lith" developers, high contrast is achieved using the "lith effect", also referred to as infectious development, as described by J.A Z. Yule in the Jou-nal of the Franklin Institute, Volume L~lsll C~ I 'WO 95/00881 PCT/US94/06353 239, 221-230, (145). The traditional "lith developers" are characterized by the presence of hydroquinone as the sole developer and a low sulfite ion concentration so as not to impede the infectious development mechanism.
However, the conventional "lith" developers suffer from a number of recognized serious deficiencies which encumber their utility. For instance, the developer exhibits low capacity as a result of the fact that it contains hydroquinone as the sole developing agent and, further, aldehyde tends to react with the hydroquinone developer to cause undesirable changes in development activity. Further, the low sulfite ion concentration is inadequate to provide effective protection against aerial oxidation. As a consequence, the conventional "lith" developer solution is lacking in stability.
One known alternative to the use of conventional "lith" developers is disclosed in U.S. Patent No. 4,269,929. This patent describes high contrast development of photographic elements as performed in the presence of a hydrazine compound with an aqueous alkaline developing solution, which has a pH of about 10 and below 12 and contains a dihydroxybenzene developing agent, a 3-pyrazolidone developing agent, a sulfite preservative, and a contrast-promoting amount of an amino compound as a "booster".
While such an amino "booster" containing developing composition yielded improvements in capacity, stability, and contrast, among other things, the inherent disadvantages of incorporating amino compounds as "boosters" in developing compositions soon became recognized in the prior art, such as 'WO 95/00881 PCT/US94/06353 toxicity, excessive volatility, lack of solubility, cost, and so forth, as explained in U.S. Patent 4,988,604.
Accordingly, another proposal has emerged in the field which involves incorporating the amino (booster) compound into the silver halide photographic element itself, so that the amino compound is utilized as a so-called "incorporated booster", such as described in U.S. Patent No. 4,914,003. In such "incorporated booster" systems, the amino compounds which function as "boosters" and also hydrazine compounds which function as "nucleators" are incorporated into a silver halide emulsion, or other hydr'ophilic colloidal layers, in the silver halide photographic element to provide a so-called "internally boosted" emulsion or one containing a hydrazine compound. For example, in this regard, representative literature includes U.S. Patent Nos. 4,988,604, 4,975,354 and 4,994,365 and World Patents WO 92/15042 and WO 93/02389.
Also, a more recent discussion and overview of internally boosted emulsion technology is described by a publication by D.L. Kerr, entitled "AN ENVIRONMENTALLY IMPROVED NUCLEATION PROCESS FOR GRAPHIC ARTS IMAGING", IS&T's 46th Ann. Conf. (1993), pages 268-270.
However, these prior art systems still relied, at least preferably, on the use of hydroquinone-based developing agents and as preferably used in a pH -3- I c SWO 95/00881 PCT/US94/06353 range of about 9 to about 10.8, such as explained in U.S. Patent N o. 4,988,604.
However, serious disadvantages from an ecological and toxilogical standpoint are associated with the use of such hydroquinone-based developing systems. For example, hydroquinone has allergenic effects. Therefore, the use of hydroquinone poses certain handling and disposal problems in view of applicable health, safety and environment guidelines and regulations.
WO 93/11456 describes a rapid access developer for hydrazinecontaining films comprising at least one alkanolamine in an amount of 5-50 g/e; at least one ascorbic acid developing agent; and having a pH in the range of 10.7 to about 12.0. The developer may further contain KOH and potassium carbonate. However, as discussed below, many alkanolamines possess the undesirable characteristic of toxicity, excessive volatility and unpleasant odor. Furthermore, alkanolamines tend to adversely affect high contrast lith image performance.' U.S. Patent No. 5,196,298, which corresponds to European Patent Application No. 0 498 968 published August 19, 1992, proposes a photographic developing solution for immersion development having a pH of at least 12.0 and containing more than 0.4 mols/liter of a sugar derivative, or an alkali metal salt thereof, such as f-ascorbic acid and iso-ascorbic acid, which preferably contains no other developing agents and no sulfite ions. The developer solution of U.S. Patent No. 5,196,298 is described as permitting die -4i± A ,WO 95/00881 PCT/US94/06353 development of graphic arts photographic materials with lith quality while permitting the disposal of the depleted developer solutions in a more environmentally ready manner. However, U.S. Patent No. 5,196,298 also states that the full benefits of that invention are achieved in a pH range of 12.3 to 13.5, which is a relatively high pH range, and which may not be acceptable to all users.
U.S. Patent No. 5,098,819 also discloses a non-hydroquinone and non-alkali metal hydroxide containing photographic developer composition.
The non-hydroquinone developer solution of this patent contains a developer selected from ascorbic acid and sugar-type derivatives thereof, together with a sulfite, an alkali metal carbonate and a 3-pyrazolidone developer compound, wherein the developer solution has a pH range of 9.75 to 10.6. The U.S. Patent 5,098,819 describes the developer composition as being subject to degradation at pH's in excess of about 10.6. Likewise, Japanese Published Patent Application No. 59-191035 published October 30, 1984, discloses a developer composition, which is especially adapted for processing a silver halide emulsion containing a black dye, wherein the developer is described as containing ascorbic acid, alkali metal carbonate, alkali metal sulfite and alkali hydroxide in a pH range of 10 to 14. However, these two latter-mentioned publications do not describe lith developers in particular, nor do these publications describe testing data which shows lith quality development.
WO 95/00881 PCT/US94/06353 However, in these patent specifications, there is no disclosure or suggestion hese developers can be used as developers for a silver halide photographic material containing a hydrazine compound as a nucleator to obtain a high contrast image.
In actuality, these above-mentioned non-hydroquinone photographic developer solutions do not permit the attainment of lith quality.
Therefore, the art has urgently awaited the discovery of a developer composition which does not require a hydroquinone developing agent while concomitantly enabling the attainment of lith quality.
SUMMARY OF THE INVENTION An object of the present invention is to provide a developer composition which does not require the presence of hydroquinone-type developer components or alkanolamines, and as a consequence, poses less of a threat to health and environment and can be more easily handled and disposed.
It is also an object of the present invention to provide a stable developer composition which is adaptable for processing standard rapid access films.
It is another object of the present invention to provide a new method for obtaining a high contrast image by using a non-hydroquinone containing -6- ~e I I':OI?!1lI'III(H22 S.l~h /1 IP) -7developer and a silver halide photographic material containing a hydrazine compound as a nucleator.
These and other objects of the present invention can be obtained by a nonhydroquinone developer composition which does not contain an alkanolamine in a concentration above 5.0g/1, comprising: a developer selected from the group consisting of ascorbic acid and sugar-type derivative, thereof, or alkali metal salts and mixtures thereof, in an amount of 0.1 to 0.4 mol/liter (mol/f); an effective amount of an auxiliary developer comprising a 3-pyrazolidone compound, an aminophenol compound or a .i mixture thereof; an alkali metal sulfite in an amount of less than or equal to 15 0.32 moi/f; an alkali metal carbonate in an amount of 0.1 to 0.4 mol/f; an alkali metal hydroxide in an amount of from 10 to 25 g/f where an ascorbic acid or sugar-type derivative thereof is 20 20 present in the form of a free acid or 3 to 15 g/A where an ascorbic acid or sugar-type derivative thereof is present in the form of an alkali metal salt; wherein the developer composition has a pH of from 10.3 to 12.5 at 25, more preferably from 10.5 or 10.8 to 11.5 or 12.2.
*WO 95/00881 PCT/US94/06353 In a preferred embodiment of the present invention, the developer composition additionally contains one or more of the following additional components: a restrainer to retard the development of non-exposed silver halide present in an amount of from 0.008 to 0.042 mol/e; an organic antifoggant agent in an amount of 0.02 to 2 g/e; and a sequestering or chelating agent in an amount of 0.5 to 3 g/f In accordance with a more preferred embodiment of the present invention, at the same time, the restrainer is selected to be an alkali metal bromide; the organic anti-fogging agent is selected to be a combination of 0.01 to 0.1 g/1 benzotriazole and 0.01 to 0.1 g/e phenyl mercaptotetrazole (PMT); and the sequestering or chelating agent is selected to be Na 2
EDTA.
In an even further preferred embodiment, the developer composition of the present invention dos not contain an alkanolamine or contains an alkanolamine in an amount of less than 5 g/f. Most preferably, the developer composition does not contain an alkanolamine. Many alkanolamines possess the undesirable characteristics of toxicity, excessive volatility and unpleasant odor. Many alkanolamines can form azeotropes with water that can complicate accurate replenishment of developer solutions, and such compounds are also quite costly. Furthermore, alkanolamines tend to accelerate the process of chemical development at the expense of physical development.
This phenomenon tends to produce an image which is more grainy than an 'WO 95/00881 PCT/US94/06353 image obtained without an alkanolamine, and is contrary to the goal of obtaining a very high contrast lith image.
The use of the developer composition of the present invention has been found to unexpectedly provide for the attainment of lith quality in an assured c manner and therefore high dot quality without the need for the presence of hydroquinone or an alkanolamine.
Another embodiment of the present invention comprises developing an image-wise exposed silver halide photographic material containing a hydrazine compound as a nucleator with a developer comprising a developing agent selected from the group consisting of ascorbic acid and sugar-type derivatives thereof, or alkali salts and mixtures thereof, and substantially free from dihydroxybenzene with the term "substantially free from dihydroxybenzene" meaning the amount of the dihydroxybenzene is less than 5 x 104 mol/e and preferably is zero. The other developer composition components described is above can also be employed in combination in this method embodiment of the present invention.
BRIEF DESCRIPTIONS OF THE DRAWINGS Figure 1 shows D-LogE curves for a EK 2000 CGP internally boosted emulsion film as processed by the developer composition of the present invention and several representative prior art developer compositions.
lp. *WO 95/00881 PCT/US94/06353 Figure 2 shows D-LogE curves for a EK 2000 CLW internally boosted emulsion film as processed by the developer composition of the present invention and several representative prior art developer compositions.
Figure 3A shows D-LogE curves for a Fuji RO-100 conventional rapid access emulsion film developed by the developer composition of the present invention and the developer of European Patent No. 0 498 968 Patent No. 5,196,298).
Figure 3B shows D-LogE curves for a Fuji RO-100 conventional rapid access emulsion film developed by the developer composition of the present to invention and the developer of U.S. Patent No. 5,098,819.
Figure 3C shows D-LogE curves for a Fuji RO-100 conventional rapid access emulsion film developed by the developer composition of the present 'nvention and the developer of Japanese Patent Application (OPI) No. 59-191035.
Figure 4A shows the D-LogE curve for different formulations of the developer composition of the present invention on an EK 2000 CGP internally boosted emulsion film.
Figure 4B shows the D-LogE curve for different formulations of the developer composition of the present invention on an EK 2000 CLW internally boosted emulsion film.
*WO 95/00881 PCT/US94/06353 Figure 4C shows the D-LogE curve for different formulations of the developer composition of the present invention on an Fuji RO-100 rapid access emulsion film.
Figure 5A shows the effect of the sodium hydroxide level, the pH value, on D-LogE curves for an EK 200 CGP internally boosted emulsion films with an ascorbic acid-based developer formulation.
Figure 5B shows the effect of the sodium hydroxide level, the pH value, on D-LogE curves for EK 200 CLW internally boosted emulsion films with an ascorbic acid-based developer formulation.
Figure 5C shows the effect of the sodium hydroxide level, the pH value, on D-LogE curves for Fuji RO-100 rapid access emulsion films with an ascorbic acid-based developer formulation.
DESCRIPTION OF THE PREFERRED EMBODIMENTS In the developer solution of the present invention, the ascorbic acid and sugar-type derivatives thereof useable as the developing agent also include stereoisomers and diastereoisomers of ascoroic acid and its sugar-type derivatives, their salts and mixtures thereof. Suitable developers which fall within the scope of the above include, but are not limited to include, f-ascorbic acid, d-erythro-ascorbic acid erythorbic or isoascorbic acid), d-gluco-ascorbic acid, 6-deoxy-f-ascorbic acid, E-rhamno-ascorbic acid, e-fucoascorbic acid, d-glucohepto-ascorbic acid, sorboascorbic acid, -11 *WO 95/00881 PCT/US94/'6353 imino-f-ascorbic acid, w-lactoascorbic acid, maltoascorbic acid, e-araboascorbic acid, e-glucoascorbic acid, d-galactoacsorbic acid, f-guloascorbic acid, and f-alloascorbic acid.
The ascorbic acids and ascorbic acid sugar derivatives of this invention, including the alkali metal salts thereof, are generally used in amount ranging from 0.1 to 0.4 mol/f, or more, and preferably used in an amount ranging from 0.14 to 0.28 mol/l in the working developer solution.
While the useful range of developer includes 0.1 to 0.4 mol/f, the useful amounts of developer can even exceed 0.4 mol/f in some circumstances, which generally will decrease the amount of auxiliary developer, such as phenidone that is needed. Preferred ascorbic acid compounds for use in the present invention as the developing agent are alkali metal ascorbates and e-ascorbic acid.
The ascorbic acids and ascorbic acid sugar derivatives of the present invention can be dissolved into the developing solution in the free acid form or, alternatively, they can be incorporated as an alkali salt, preferably the sodium or potassium salt thereof, or as a mixture of both free acid form and salt thereof. In the case of the use of the salt form of the developer, a lesser amount of alkali hydroxide is needed to establish a pH of 10.3 to 12.5, for example, an amount of about 3 to 15 g/f alkali hydroxide is generally used.
On the other hand, if the free acid form of the sugar is used alone, 10 to grams per liter of alkali metal hydroxide is usually employed to adjust the pH -12-
I
~Y I~ *WO 95/00881 PCT/US94/06353 to 10.3 to 12.5. Other examples of useable ascorbic acid and sugar-type derivatives useable as the developing agent for the developing solution of the present invention are described in U.S. Patent Nos. 5,098,819 and 5,196,298, with the disclosures of which being incorporated by reference herein.
An auxiliary developing agent comprising a 3-pyrazolidone (or derivative thereof)(phenidone), an aminophenol compound or a mixture thereof is also included in the developer solution of the present invention in order to enhance the speed of the development of the developer composition.
Useable 3-pyrazolidone developing agents are disclosed, for example, in U.S. Patent No, 5,098,819, the disclosure of which is incorporated by reference with 1-phenyl-3-pyrazolidone being preferred. Suitable aminophenols which can be used include p-methylamino-phenol (melol) and those disclosed in U.S. Patent 4,914,003, the disclosure of which is incorporated by reference. The auxiliary developing agent is used in an effective amount to achieve high density and high contrast. Such is generally used in an amount of from 0.001 to 0.12 mol/e, and preferably is used in an amount of from 0.001 to 0.006 mol/e for the 3-pyrazolidone or 0.001 to 0.02 mol/e for the p-aminophenol.
The developer composition of the present invention can be successfully employed without the need of any hydroquinone-type developer or an alkanolamine. However, other important addenda to the developer composition of the present invention include an alkali metal sulfite, preferably -13- I- I P- ~1 "WO 95/00881 PCT/US94/06353 sodium sulfite (NaS0 3 used in an amount of up to 0.32 mol/e, preferably from 5 to 30 g/f (where Na,S0 3 is used), as a preservative and stabilizer against aerial oxidation. Other useable sulfites are disclosed in U.S. Patent No. 5,098,819, which is incorporated by reference.
The full benefits of this invention are obtained in a pH range of 10.3 to 12.5, more preferably from 10.5 or 10.8 to 11.5 or 12.2. Further, the alkalinity of the developer composition is maintained within the desired range by the presence of an alkali metal carbonate such as sodium or potassium carbonate in an amount of 0.1 to 0.4 mol/e or less, preferably from 0.14 to 0.28 mol/f. The alkali metal carbonate is preferably used in conjunction with an alkali metal hydroxide in an amount of 3 to 25 g/e to adjust the pH range to the desired range. The amount of alkali hydroxide added partly depends on whether the developer is used in a fre: acid from, where the amount of alkali hydroxide is generally used in an amount of 10 to 25 g/f, or if the developer is used in salt form, where the amount of alkali hydroxide is generally used in an amount of 3 to 15 g/e.
In general, the alkali metal carbonates give rise to less caustic compositions than alkali metal hydroxides. However, on the other hand, alkali metal carbonates typically require greater amounts to be present to effect a pH adjustment in comparison to alkali hydroxides. With this tradeoff in mind, it is preferred in the present invention that the alkalinity of the developer solution be established through a discretionary selection of amounts -14a I I~ I I __I IWO 95/00881 PCT/US94/06353 for each of alkali metal carbonate and alkali hydroxide, and with refinements made to the pH preferably being made by supplemental addition of alkali metal hydroxide.
The developer composition of the present invention also can contain a wide variety of other conventional additives and addenda, which serve other various desirable functions. For instance, these additional addenda include, but are not limited to, additional developing agents other than hydroquinone, antifogging agents, buffers, sequestering agents, swelling control agents, development accelerators, and so forth.
However, in a more preferred embodiment of the present invention, the developer solution contains certain other addenda including each of a restrainer agent, an organic antifogging agent and a sequestering or chelating agent.
For example, sodium or potassium bromides are preferably included as restrainers in an amount of about 0.008 to 0.04 mol/l. Exemplary organic anti-fogging agents preferably include a combination of a benzotriazole and phenyl mercaptotetrazole each in an amount of 0.01 to 0.1 g/e, respectively.
Useful benzotriazoles are disclosed, for example, in U.S. Patent No. 4,975,354, the disclosure of wkdch is incorporated by reference. An exemplary mercaptotetrazole is *WO 95/00881 PCT/US94/06353 Moreover, the present invention also encompasses the use of other antifogging agents, such as disclosed in U.S. Patent Nos. 5,098,819 and 5,196,298, the disclosures of which are incorporated by reference.
A small amount of a sequestering or chelating agent is generally used to sequester trace amounts of metal ions present in the components or water used in formulating the developer formulation. Exemplary sequestering agents useable in the present invention are disclosed by U.S. Patent No. 5,098,819, incorporated herein by reference, and are generally used in an amount of to 3 g/1, preferably from 0.5 to 2.0 g/f. Preferably, the sequestering agent used in the present invention is Na 2 EDTA in the above amounts.
The developing solutions of the present invention can be employed to develop various types of photographic materials, especially black-and-white photographic elements including conventional rapid access films, such as Fuji RO-100 film by Fuji Photo Film Co., Ltd., as well as silver halide photographic materials containing a hydrazine compound as a nucleator, such as EK 2000 CGP and EK 2000 CLW film manufactured by Eastman Kodak Company. However, the utility of the developing solution of the present invention is not limited thereto and is understood to extend to other black-and-white materials such as radiographic recording and duplicating materials, cinematographic recording and duplicating materials and microfilm.
However, the benefits of the present invention become especially apparent when using the inventive developer solution to develop graphic arts 16- I -II I Ir~--rsl .WO 95/00881 PCT/US94/06353 photographic materials and silver halide photographic materials containing a hydrazine compound as a nucleator for lith quality and therefore high dot quality.
The photographic elements which can be developed by the developer's solution of the present invention can take on conventional layering schemes such as disclosed in U.S. Patent No. 5,198,298, which is incorporated by reference herein.
Another example of films which can be used in the present invention is a silver halide photographic material containing a hydrazine compound as a nucleator. Such photographic materials are shown in, for example, U.S. Patent 4,975,354, 4,988,604 and 4,994,365 with respect to the layer structure, the silver halide emulsion, the internal booster, and other components of the photographic material. The disclosures of these patents are incorporated by reference.
Non-limiting examples of hydrazine compounds are the following compounds: 0 CH- COCHCHCH 6- S-CHaCNH -50 2 NH NHNHCHO 0
C
2 Hs-COCH 2
CH
2 6 -S-CHCNH- SO 2 NH NHNHCHO 17i
I
*WO 95/00881 PCT/US94/06353 C I- 0
CH
3
N
-CHCNH 502NH NHNHCHO
CH
3 C- 0 I1\
CH
3
N--CH
2 CNH SO 2 NH NHNHCHO
CH,
Other hydrazine compounds which can be used in the photographic material, include those described in RESEARCH DISCLOSURE, Item 23516 (November, 1983, page 346) and the literature references referred to therein, as well as in U.S. Patents 4,080,207, 4,269,929, 4,276,364, 4,278,748, 4,385,108, 4,459,347, 4,560,638, 4,478,928, 4,737,452, 4,284,764, 4,686,167, 5,100,761, 5,006,445, 4,960,672, 4,971,890, 4,971,888, 4,950,578, 5,061,594, 5,017,456, 5,028,510, European Patent 217,310, European Patent 286,840 and British Patent 2,011,391. The hydrazine compound may be introduced in any hydrophilic colloid layer of the photographic material, such as a silver halide emulsion layer, an inter layer, a protective coating layer, etc.
The amount of the hydrazine compound present in the photographic material is preferably from 1 x 10" mol to 5 x 10- 2 mol, especially preferably from 1 x 10 mol to 2 x 10 mol, per mol of silver halide in the photographic light-sensitive element.
18- Ir t- SWO 95/00831 PCT/US94/06353 The photographic material to be developed by the developing solutions of the present invention can be image-wise exposed by any convenient radiation source in accordance with this specific application.
For processing, preferably an automatically operating apparatus is used provided with a system for automatic replenishment of the processing solutions. The development step can be followed by a stop step, for example, using a stopping solution such as a 3% acetic acid solution used at approximately 90°F for 15 seconds, followed by a fixing bath, for example, using a commercially available fixer, such a F-O-G available from Fuji Hunt Photographic Chemicals, Inc., used at about 90°F for 30 seconds, followed by a washing or stabilization step. Finally, the photographic material is dried according to standard practices.
The following examples are illustrative of the present invention but are not to be construed as limiting thereto. All amounts are in grams per liter unless otherwise indicated.
EXAMPLES
Example 1: The photographic performance of a developer formulation representing the present invention (solution 7) was compared with examples from JP 59-191035 (solution European Patent 0 498 968 (solutions 2 and 3), U.S. Patent 5,098,819 (solutions 4, 5 and 6) and the commercially available 19-
III
'WO 95/00881 W0 9500881PCTIUS94/06353 Kodak RA 2000 hydroquinone developer (reference solution). The various developer formulations that were evaluated are summarized in Table 1-1 below.
Table 1-1 Inqredient L-Ascarbic Acid D-Sodiuii Ascarbate Sodiumi SuLfite Sodium Metabisulfite Sodium Carbonate Potassium carbonate Na 2
EDTA
Na 4
EDTA
Phenidone 4-(Hydraxymnethyt methyL -1 -phenyL -3pyrazoL idone Senzotriazole 1 -PhenyL -mercaptotatrazole Sodim Bromide Potassium Bromide Sodium Hydroxide Potassium Hydroxide
PH
4 5 6 7 31.5 79.3 25.5 5.0 12.5 2.5 1.9 24.0 26.4 24.0 0.3 0.08 25 15.4 55.6 4' 2.05 12.35 1: 0.6 2.3 0.6 2.0 1.04 0.09 0.09 0.08 0.008 0.008 2.7 10.0 2.7 0.3 0.02 0.01 14.5 i 25 3.0 10.38 10.16 10.04 12.05 Three different types of photographic films were developed by each developer solution tested. Two of the films were commercially available internally boosted (IB) types, namely Kodak CGP (for halftone work and Kodak CLW (for line work), while the third film was a commerci"'Udy available rapid access film, namely FUJI RO-100 film.
The developing conditions used were a temperature of 90' F and a developing time of 30 seconds for CGP and CLW films and 25 ser,,-nrd for 20 -WO 95/00881 PCT/US94/06353 RO-100 film. Afterwards, a stop bath acetic acid soln.) was used at F for 15 seconds. Then a fix bath (commercially available F-O-G fixer with hardener from Fuji Hunt Photographic Chemicals, Inc.) was used at F for 30 seconds.
The results are shown graphically in Figures 1, 2, 3A, 3B and 3C, wherein represents results for Kodak RA 2000; A represents results for the solution 1 developer; o and represent results for solutions 2 and 3, respectively; A, o, and v represent results for solutions 4, 5 and 6, respectively; and 0 represents results for solution 7 representing the present invention.
More specifically, Figure 1 shows D-LogE curves for a EK 2000 CGP internally boosted emulsion film as processed by the developer composition of the present invention and several representative prior art developer compositions.
Figure 2 shows D-LogE curves for a EK 2000 CLW internally boosted emulsion film as processed by the developer composition of the present invention and several representative prior art developer compositions.
Figure 3A shows D-LogE curves for a Fuji RO-100 rapid access emulsion film developed by the developer composition of the present invention and the developer of European Patent No. 0 498 968 Patent No. 5,196,298).
Figure 3B shows D-LogE curves for a Fuji RO-100 rapid access emulsion film developed by the developer composition of the present invention and the developer of U.S. Patent No. 5,098,819.
Figure 3C shows D-LogE curves for a Fuji RO-100 rapid access emulsion film developed by the developer composition of the present invention and the developer of Japanese Patent Application (OPI) No. 59-191035.
As to the results themselves, the sharp slope in the D-LogE curves for the inventive soln. 7 in Figures 1 and 2 indicate lith quality for the Kodak -21rr I 'WO 95/00881 PCT/US94/06353 CGP and CLW IB emulsions. This effect is truly unexpected because lith quality was not observed for the other investigated prior art non-hydroquinone developer chemistries of EP 0 498 968 (which provide high contrast on EK CGP film but the D. is unacceptably low) and U.S. patent 5,098,819, as indicated by the curves for solutions 1-6 in Figures 1 and 2. Lith quality was observed for Kodak RA 2000 developer, which is a conventional hydroquinone type developer. Yet, the soln. 7 curve is sharper than that for the Kodak RA 2000, which indicates a better performance of the Kodak emulsions with the developer composition of the present invention.
The comparative slopes 'n the D-LogE curve in Figure 3 for the RO-100 standard rapid access emulsion (not hydrazine containing) shows that soln. 7 gives comparable and useful results to other ascorbic acid based chemistries. Also, high fog levels were observed for the Japanese Published Patent Application 59-191035 formulation (elevated density at low step number), as shown in Figs. 1, 2, 3C. Also, unsatisfactorily low densities are obtained at high step numbers for the European Patent No. 0 498 968 solutions, as shown in Figs. 1 2.
Example 2: In this example, the amount of sulfite, bromide, alkali hydroxide, ascorbic acid, and pH were adjusted as shown in Table 2-1 (all amounts are in g/f, unless indicated otherwise) to evaluate and compare results for the three same type of films used in Example 1. The same developing conditions as Example 1 were used.
-22- I I
__I
WO 95/00881 PCT/US94/06353 Examples NaCO 3 Na 2 SO3 Phenidone Na 2
EDTA
Benzotriazole
PMT
KBr NaOH (97%) e-Ascorbic acid Deionized (DI) Water to make Final pH
B
30 5 0.3 1.0 0.02 0.01 1.0 15.62 50 1t 10.99 Table 2-1
C
30 15 0.3 1.0 0.02 0.01 2.0 19.26 50 1e 11.49
D
30 30 0.3 1.0 0.02 0.01 1.0 12.23 30 1i 11.50
E
0.3 0.02 0.01 15.14 1e 12.18 The results are summarized in Figures 4A, 4B and 4C, wherein represents results for Example B; a represents results for Example C; o represents results for Example D; and represents results for Example E.
In general, Figure 4A shows the D-LogE curve for different formulations of the developer composition of the present invention on an EK 2000 CGP internally boosted emulsion film.
Figure 4B shows the D-LogE curve for different formulations of the developer composition of the present invention on an EK 2000 CLW internally boosted emulsion film.
-23- O~I 'WO 95/00881 PCTUS94/06353 Figure 4C shows the D-LogE curve for different formulations of the developer composition of the present invention on an Fuji RO-100 rapid access emulsion film.
Example 3: The effect of sodium hydroxide level, and, hence the pH value, was examined for the same three types of films used in Example 1 with the formulations used in Table 3-1 (all amounts are in g/e, unless indicated otherwise). The same developing conditions were used as in Example 1.
-24- Iwo 95/00881 ~WO 9500881PCT/US94/06353 Table 3-1 Examples F G H NaC0 3 30 30 Na.,S0 3 30 30 Phenidone 0.03 0.03 0.03 Na 2 EDTA 1.0 1.0 Benzotriazole 0.02 0.02 0.02 PMT 0.01 0.01 0.01 KBr 1.0 1.0 D-Sodium Ascorbate 36.8 36.8 36.8 NaOH -5.14 7.88 DI water to make if if it Final pH 10.25 11.29 12.01 The results are summarized in Figures 5A, 5B and 5C, wherein represents the results for Example F; A represents the results for Example G; and o represents the results for Example H.
Figure 5A shows the effect of the sodium hydroxide level, L the pH value, on D-LogE curves for an EK 2000 CGP internally boosted emulsion films with an asporbic acid-based developer formulation.
25 ;WO 95/00881 PCT/US94/06353 Figure 5B shows the effect of the sodium hydroxide level, the pH value, on D-LogE curves for EK 2000 CLW internally boosted emulsion films with an ascorbic acid-based developer formulation.
Figure 5C shows the effect of the sodium hydroxide level, the pH value, on D-LogE curves for Fuji RO-100 rapid access emulsion films with an ascorbic acid-based developer formulation.
The results shown in Figures 5A-5C demonstrate the unexpected importance of the pH value selected, especially for the internally boosted (IB) films.
Example 4: In addition to D-LogE ,urves, dot quality investigations also were made on the same developer formulations as solutions 1-7 and EK RA 2000 of Example 1 (Table and on same three types of films used in Example 1. In general, dot quality is a standard methodology for evaluating the quality of lith developers. The better the lith quality, the be'ter the dot quality. The sharper the dot, the lower the numerical rating assigned.
Dot coverage of 10, 50 and 90% of total ar?,a were used. Base fog results compare to density of low step number in the graph. D max and Gradient (Grad.) quantitative results were also examined and measured. The results of these analyses are summarized below.
-26- I Wo 95/00881 WO 9500881PCTJUS94/06353 TABLE 4A SENSITOMETRIC RESULT ON THE HYDRAZINE CONTAINING EMULSION (EK CGP FILM) PROCESSED IN DIFFERENT DEVELOPERS EK RA 2000 5.20 Grad. 12.6 B.F. 0.02 Soin. 1 Samn. 2 Soln. 3 Soln. 4 Soln. 5 Soam. 6 Soln. 7 5.20 7.2* 4.60 13.8 4.11 12.6 5.22 7.9 8.3 7.8 15.7 0.03 0.03 NOTE: Gradation (Grad.) was measured between densities 1.0 and 3.0. Grad. with *was measured between densities 1.5 and TABLE 4B DOT QUALITY ON THE HYDRAZINE CONTAINING EMULSION (EK CGP FILM) PROCESSED IN DIFFERENT DEVELOPERS EK RA 2000 50% 90% RATING 5 2-3 3-4 Salii. 4 50% 90% RATING 6 6 7 Solxi. 1 10% 50% 90% NA NA NA Soln. 5 10% 50% 90% 6 6 7 Soln. 2 10% 50% 90% 3-4 2 3-4 Soln. 6 10%.50% 90% 6 6 7 Soln. 3 10% 50% 3 1-2 3 Samn. 7 10% 50% 2-3 1 2-3 NOTE: 1) DOT QUALITY RATING: L,,cdlent~l, very good=2, extremely poor=7 2) 10%, 50%, 90% area were e; good=3, fine=4, poor=5, very poor=6, 27 WO 95/00881 PTU9/65 PCT/US94/06353 TABLE SENSITOMETRIC RESULT ON THE HYDRAZINE CONTAINING EMULSION (EK CLW FILM) PROCESSED IN DIFFERENT DEVELOPERS EK RA 2000 4.44 Grad. 19.9 B.F. 0.02 Soin. I Soln. 2 Soln. 3 Soln. 4 Soin. 5 Soin. 6 Soln. 7 4.60 5.4* 0.87 3.27 4.77 4.65 7.0 6.4 4.8 5.1 4.6 26.1 0.03 0.03 0.02 NOTE: Gradation (Grad.) was measured between densities 1.0 and 2.0. Grad. with *was measured between densities 2.0 and TABLE SB DOT QUALIT Y ON THE HYDRAZINE CONTAINING EMULSION (EK CLW FILM) PROCESSED IN DIFFERENT DEVELOPERS EK RA 2000 50% 90% RATING 5 3 3 Soln. 4 50% 90% RATING 6 6 7 Sohi. 1 10% 50% 90% NA NA NA Samn. 5 10% 50% 90% 6 6 7 Samn. 2 10% 50% 90% 5 2-3 3-4 Soln. 6 10% 50% 90% 6 6 7 Soln. 3 50% 4 2 3 Soln. 7 10% 50% 21 1 NOYE: 1) DOT QUALITY RATING, Exceilent=1, very good=2, good=3, fine=4, poor=5, very poor=6, extremely poor=7 2) 10%, 50%, 90% area were examined 28 *WO 95/00881 W0 9500881PCTIUS94/06353 TABLE 6A SENSITOMETRIC RESULT ON CONVENTIONAL RAPID ACCESS EMUJLSION (FUJI RO-100 FILM) PROCESSED IN DIFFERENT DEVELOPERS EK RA 2000 5.31 Grad. 8.0 B.F. 0.04 Soln. 1 Soln. 2 Soln. 3 Soln. 4 Samn. 5 Soln. 6 Soln. 7 5.29 5.20 11.2 0.18 14.8 0.08 7.0 6.3 5.5 5.6 0.05 0.05 NOTE: Gradation (Grad.) was measured between densities 1.0 and 3.0. Grad, with *was measured between densities 1.5 and TABLE 6R DOT QUALITY ON CONVENTIONAL RAPID ACCESS EMULSION (FUJI FILM) PROCESSED IN DIFFERENT DEVELOPERS EK RA 2000 50% 90% RATING 6 6 7 Solii. 4 50% 90% RATING 6 6 7 Soln. 1 10% 50% 90% NA NA NA Samn. 5 10% 50% 90% 6 6 7 Salix. 2 10% 50% 90% 5 2-3 7 Soln. 6 10% 50% 90% 66 7 Samn. 3 10% 50% 4-5 3-4 6 Samn. 7 10% 50% 6 5 NOTE: 1) DOT QUALITY RATING: Excellent=1, very good=2, extremely poor=7 2) 10%, 50%, 90% area are exat gaod=3, fme=4, poor=5, very paor=6, r 29 'Wo 95/00881 WO 9500881PCT/US94/06353 TABLE 7A SENSITOMETRIC RESULT ON THE HYDRAZINE CONTAINING EMULSION AND CURRENT RA EMULSION PROCESSED IN DIFFERENT DEVELOPERS EK CGP FILMf ETC CLW FILM Ex.B Ex.C Ex.D Ex.E Ex.B Ex.C Ex.D Ex.E 5.19 Grad. 12.9 B.F. 0.02 5.20 5.20 5.23 4.35 18.9 24.4 19.3 21.5* 0.02 0.02 0.03 0.02 4.46 15.1* 0.02 4.40 24.8* 0.02 4.45 25.3* 0.02 FUJI RO-100 FILM Ex.B Ex.C Ex.D Ex.E 5.25 5.25 5.25 5.22 Grad. 7.4 7.5 7.1 6.2 B.F. 0.04 0.04 0.04 0.04 NOTE:Gradatian (Grad.) was measured between densities 1.0 and 3.0. Grad, with* was measured between densities 1.0 and TABLE 7B DOT QUALITY ON THE HYDRAZINE CONTAINING EMULSION (CGP CLW) AND CONVENTIONAL RA EMULSION (RO..100) PROCESSED IN DIFFERENT DEVELOPERS Ex.B 50% 90% RATING 5 2 1-2 ETC CGP FILM Ex.C Ex.D 10% 50% 90% 10% 50% 90% 3-4 1 1-2 3-4 1 2-3 Ex.B 50% 90% RATING 4-5 2-3 1 Ex.B 50% 90% RATING 6 6 7 EK CLW FILM EX.c 10% 50% 90% 3 1 1 Ex.D 10% 50% 90% 3 1 1 10% 50% 2-3 1 2-3 Ex.E 10% 50% 1 1 1-2 Ex.E 10% 50% 6 5 FUJI RO-100 FILM Ex.c Ex.D 10% 50% 90% 10% 50% 90% 6 5 7 6 5 7 30 Vo 95/00881 ~WO 9500881PCT/US94/06353 TABLE 8A SENSITOMETRIC RESULT ON THE HYDRAZINE CONTAINING EMULSION AND CONVENTIONAL EMULSION PROCESSED IN DIFFERENT DEVELOPERS EK CGP FILM Ex.F' Ex.G 2 Ex.H 3 EK CLW FILM Ex.F Ex.G Ex.H D. 5. 11 Grad. 5.2 B.F. 0.02 5.19 11.9 0.02 5.23 19.9 0.02 4.13 4.27 4.7* 19.9* 0.02 0.02 4.33 17.2* 0.02 FUJI RO-100 FM Ex.F Ex.G Ex.H 4.53 Grad. 5.5 B.F. 0.03 5.21 5.21 6.8 0.04 0.05 NOTE:Gradation (Grad.) was measured between densities 1.0 and 3.0. Grad. with* was measured between densities 1.0 and TABLE 8B DOT QUALITY ON THE HYDRAZINE CONTAINING EMULSION (CGP CLW) AND CONVENTIONAL RA EMULSION (RO-100) PROCESSED IN DIFFERENT DEVELOPERS EK CGP FILM Ex.F 50%
EX.G
10% 50% Ex.H 10% 50% 90% RATING 6 6 5 4-5 2-3 4 4 2 4 EK CLW FILM Ex.F 50% Ex.G 10% 50% Ex.H 10% 50% 90% RATING 6 6 6 5 3 4 4 2-3 3-4 FUJI RO-100 FILM
EX.F
50% Ex.G 10% 50% Ex.H 10% 50% 90% RATING 6 6 7 6 6 7 6 6 IWithout NaOH, pH 10.27; 1 With NaOH, pH 11.30; 3 With NaGH, pH 12.00 31
I
WO 95/00881 PCT/US94/06353 While the invention has been described in detail and with reference to the specific embodiments thereof, it will be apparent to one skilled in the art that various changes and modifications can be made thereto without departing from the spirit and scope thereof.
Throughout this specification and the claims which follow, unless the context requires otherwise, the word "comprise", or variations such as "comprises" or "comprising", will be understood to imply the inclusion of a stated integer or gr.ap of integers but not the exclusion of any other integer or group of integers.
S
o o :o o -32-
Claims (32)
1. A non-hydroquinone photographic developer composition which does iot contain an alkanolamine in a concentration above 5.0 g/9, comprising: a developer selected from the group consisting of ascorbic acid and sugar-type derivatives thereof, or alkali metal salts and mixtures thereof, in an amount of 0.1 to 0.4 mol/liter (mol/); an effective amount of an auxiliary developing agent comprising a 3-pyrazolidone compound, an aminophenol or a mixture thereof; 10 an alkali metal sulfite in an amount less than or equal to 0.32 mol/t; an alkali metal carbonate in an amount of 0.1 to 0.4 mol/; an alkali metal hydroxide in an amount of from 10 to 25 g/9 where an ascorbic acid or sugar-type derivative thereof is present in the form of a free acid or from 3 to g/9 where an ascorbic acid or sugar-type derivative thereof is present in the form of 15 an alkali metal salt; wherein the developer composition has a pH of from 10.3 to 12.5 at
2. A non-hydroquinone photographic developer composition of claim 1 wherein the composition is substantially free of dihydroxy benzene as hereinbefore defined.
3. The non-hydroquinone photographic developer comp 'tion of claim 1, wherein said developer is selected from the group consisting of 9-ascorbic acid, d-erythroascorbic acid, d- gluco-ascorbic acid, 6-deoxy-g-ascorbic acid, I-rhamno-ascorbic acid, t-fucoascorbic acid, d- glucohepto-ascorbic acid, sorboascorbic acid, imino-4-ascorbic acid, to-lactoascorbic acid, maltoascorbic acid, -araboascorbic acid, C-glucoascorbic acid, d-galactoascorbic acid, 9- guloascorbic acid and 9-alloascorbic acid.
4. The non-hydroquinone photographic developer composition of claim 1, wherein said developer comprises an alkali metal salt of ascorbic acid. I P;\OPER\PDB\I22-95,CLM.- 12/1/8 -34- The non-hydroquinone photographic developer composition of claim 1 wherein said developer composition does not contain an alkanolamine.
6. A non-hydroquinone photographic developer composition which does not contain an alkanolamine in a concentration above 5.0 g/e, comprising: a developer selected from the group consisting of ascorbic acid and sugar-type derivatives thereof, or alkali metal salts and mixtures thereof, in an amount of 0.1 to 0.4 mol/liter (mol/t); an effective amount of an auxiliary developing agent comprising a 3-pyrazolidone 10 compound, an aminophenol or a mixture thereof; an alkali metal sulfite in an amount less than or equal to 0.32 mol/9; an alkali metal carbonate in an amount of 0.1 to 0.4 mol/9; an alkali metal hydroxide in an amount of from 10 to 25 g/ where an ascorbic acid or sugar-type derivative thereof is present in the form of a free acid or from 3 to 15 where an ascorbic acid or sugar-type derivative thereof is present in the form of an alkali metal salt; 0 wherein the developer composition has a pH of from 10.3 to 12.5 at and additionally one or more of a restrainer to retard the development of non-exposed silver halide present in an amount of from 0.008 to 0.04 mol/t; an organic antifoggant agent in an amount of 0.02 to 2g/f; and a sequestering or chelating agent in an amount of 0.5 to 3 g/Q.
7. A non-hydroquinone photographic developer composition of claim 6 wherein the composition is substantially free of dihydroxy benzene as hereinbefore defined.
8. The non-hydroquinone photographic developer composition of claim 6, wherein said developer is selected from the group consisting of 9-ascorbic acid, d-erythroascorbic acid, d-gluco-ascorbic acid, 6-deoxy-l-ascorbic acid, I-rhamno-ascorbic acid, -fucoascorbic acid, za30 d-glucohepto-ascorbic acid, sorboascorbic acid, imino--ascorbic acid, o-lactoascorbic acid, -I PAOPIER\PD\0922.9,CLM. 121/98 maltoascorbic acid, -araboascorbic acid, -glucoascorbic acid, d-galactoascorbic acid, -guloascorbic acid and 9-alloascorbic acid.
9. The non-hydroquinone photographic developer composition of claim 6, wherein said developer comprises an alkali metal salt of ascorbic acid. The non-hydroquinone photographic developer composition of claim 6, wherein said restrainer comprises sodium bromide; said organic anti-fogging agent comprises a mixture of benzotriazole and 1-phenyl-5-mercaptotetrazole; and said sequestering agent comprises 10 Na 2 EDTA.
11. The non-hydroquinone photographic developer composition of claim 6, wherein said developer composition does not contain an alkanolamine. 15 12. A method of developing an image-wise exposed black-and-white photographic material :.I comprising developing said photographic material with a non-hydroquinone developer ""composition which does not contain an alkanolamine in a concentration above 5.0 g/, comprising: i a developer selected from the group consisting of ascorbic acid and sugar-type derivatives thereof, or alkali metal salts and mixtures thereof, in an amount of 0.1 to 0.4 mol/liter (mol/); an effective amount of an auxiliary developing agent comprising a 3-pyrazolidone compound, an aminophenol or a mixture thereof; an alkali metal sulfite in an amount less than or equal to 0.32 mol/t; an alkali metal carbonate in an amount of 0.1 to 0.4 mol/t; an alkali metal hydroxide in an amount of from 10 to 25g/9 where an ascorbic acid or sugar-type derivative thereof is present in the form of a free acid or from 3 to 15g/9 where an ascorbic acid or sugar-type derivative thereof is present in the form of an alkali metal salt, Z wherein the developer composition has a pH of from 10.3 to 12.5 at III P:)OPR\PDB\10922-9.CLM. 121/98 -36-
13. A non-hydroquinone photographic developer composition of claim 12 wherein the composition is substantially free of dihydroxy benzene as hereinbefore defined.
14. The method of claim 12, wherein said developer is selected freo. the group consisting of -ascorbic acid, d-erythro-ascorbic acid d-gluco-ascorbic acid, 6-deoxy-g-ascorbic acid, 2- rhamno-ascorbic acid, 9-fucoascorbic acid, d-glucohepto-ascorbic acid, sorboascorbic acid, imino-g-ascorbic acid, co-lactoascorbic acid, maltoascorbic acid, 9-araboascorbic acid, 2- glucoascorbic acid, d-galactoascorbic acid, 9-guloascorbic acid and 9-alloascorbic acid. 10 15. The method of claim 12, wherein said developer comprises an alkali metal salt of ascorbic acid.
16. The method of claim 12, wherein said developer additionally includes at least one of a restrainer to retard the development of non-exposed silver halide in an amount of from 9 9 15 0.008 to 0.4 mol/Q; an organic antifoggant agent in an amount of 0.02 to 2 g/9; and a sequestering agent in an amount of 0.5 to 3g/.
17. The method of claim 12, wherein said developer composition does not contain an alkanolamine.
18. A method of developing an image-wise exposed black-and-white photographic material comprising developing said material with a non-hydroquinone developer composition which does not contain an alkanolamine in a concentration above 5.0 g/9, comprising: a developer selected from the group consisting of ascorbic acid, sugar-type derivatives of ascorbic acid, alkali metal salts of ascorbic acid and mixtures thereof, in an amount of 0.14 to 0.28 mol/t; an effective amount of an auxiliary developing agent comprising a 3-pyrazolidone compound, an aminophenol or a mixture thereof; an alkali metal sulfite in an amount less than or equal to 0.32 mol/9; Q an alkali metal carbonate in an amount of from 0.14 to 0.28 mol/9; P:OPPR"BUO\MP9I2.SCLM lV2Il8 -37- an alkali metal hydroxide in an amount of from 3 to 25 g/9; a restrainer in an amount of from 0.008 to 0.04 mol/C; an organic antifoggant agent in an amount of 0.02 to 0.2g/; and a sequestering or chelating agent in an amount of from 0.5 to 2g/ wherein the developer composition has a pH of from 10.3 to 12.5 at 25 0 C.
19. A non-hydroquinone photographic developer composition of claim 18 wherein the composition is substantially free of dihydroxy benzene as hereinbefore defined. 10 20. The method of claim 18, wherein said developer is selected from the group consisting of e-ascorbic acid, d-erythroascorbic acid, d-gluco-ascorbic acid, 6-deoxy-4-ascorbic acid, I- rhamno-ascorbic acid, 9-fucoascorbic acid, d-glucohepto-ascorbic acid, sorboascorbic acid, imino-4-ascorbic acid, o-lactoascorbic acid, maltoascorbic acid, 9-araboascorbic acid, 9- glucoascorbic acid, d-galactoascorbic acid, -guloascorbic acid and -alloascorbic acid. 1
21. The method of claim 18, wherein said developer comprises an alkali metal salt of S ascorbic acid. S22. The method of claim 18, wherein said restrainer comprises sodium bromide; said organic anti-fogging agent comprises a mixture of benzotriazole and mercaptotetrazole; and said sequestering agent comprises Na 2 EDTA.
23. The method of claim 18, wherein said developer composition does not contain an alkanolamine.
24. A method of obtaining a high contrast image comprising developing an image-wise exposed silver halide photographic material containing a hydrazine compound with a non- hydroquinone developer composition which does not contain an alkanolamine in a concentration above 5.0 g/9, comprising: a developing agent selected from the group consisting of ascorbic acid and sugar-type 1 PIAOPP3RWPDflIOM9229.CLM 12/1/98 -38- derivatives thereof, or alkali metal salts and mixtures thereof in an amount greater than 0.1 mol/liter said composition being substantially free of dihydroxy benzene as hereinbefore defined.
25. The method of claim 24, wherein said developing agent is selected from the group consisting of e-ascorbic acid, d-erythroascorbic acid, d-gluco-ascorbic acid, 6-deoxy-- ascorbic acid, 9-rhamno-ascorbic acid, -fucoascorbic acid, d-glucohepto-ascorbic acid, sorboascorbic acid, imino-e-ascorbic acid, o-lactoascorbic acid, maltoascorbic acid, araboascorbic acid, -glucoascorbic acid, d-galactoascorbic acid, 9-guloascorbic acid and 9- 9 10 alloascorbic acid.
26. The method of claim 24, wherein said developing agent comprises an alkali metal salt of ascorbic acid. 15 27. The method of claim 24, wherein said developer composition does not contain an alkanolamine.
28. A method of obtaining a high contrast image comprising developing an image-wise exposed silver halide photographic material containing a hydrazine compound with a non- hydroquinone developer composition which does not contain an alkanolamine in a concentration above 5.0 g/Q, comprising: a developing agent selected from the group consisting of ascorbic acid and sugar-type derivatives thereof, or alkali metal salts and mixtures thereof in an amount of 0.1 to 0.4 mol/liter (mol/9); an effective amount of an auxiliary developing agent comprising a 3-pyrazolidone compound, an aminophenol or a mixture thereof; an alkali metal sulfite in an amount less than or equal to 0.32 mol/9; an alkali metal carbonate in an amount of 0.1 to 0.4 mol/9; an alkali metal hydroxide in an amount of from 10 to 25 where an ascorbic acid /0 or sugar-type derivative thereof is present in the form of a free acid or from 3 to P:\OIILR\PDB\10922.9.cM IVIs -39- where an ascorbic acid or sugar-type derivative thereof is present in the form of an alkali metal salt; wherein the developer composition has a pH of from 10.3 to 12.5 at and is substantially free of dihydroxy benzene as hereinbefore defined.
29. The method of claim 28, wherein said developer is selected from the group consisting of -ascorbic acid, d-erythroascorbic acid, d-gluco-ascorbic acid, 6-deoxy-Q-ascorbic acid, Q- rhamno-ascorbic acid, 9-fucoascorbic acid, d-glucohepto-ascorbic acid, sorboascorbic acid, imino-g-ascorbic acid, to-lactoascorbic acid, maltoascorbic acid, -araboascorbic acid, 9- 10 glucoascorbic acid, d-galactoascorbic acid, 9-guloascorbic acid and -alloascorbic acid.
30. The method of claim 28, wherein said developing agent comprises an alkali metal salt Sof ascorbic acid. 15 31. The method of claim 28, wherein said developer composition additionally includes at least one of a restrainer to retard the development of non-exposed silver halide in an amount of from 0.008 to 0.04 mol/; an orga.L, antifoggant agent in an amount of 0.02 to 2 g/9; and a sequestering agent in an amount of 0.5 to 3 g/9.
32. The method of claim 31, wherein said restrainer comprises sodium bromide; said organic anti-fogging agent comprises a mixture of benzotriazole in an amount of 0.01 to g/9 and l-phenyl-5-mercaptotetrazole in an amount of from 0.01 to 1.0 g/C; and said sequestering agent comprises Na 2 EDTA.
33. The method of claim 28, wherein said silver halide photographic material includes at least one emulsion layer or hydrophilic colloid layer comprising an amino compound in an amount effective to act as an incorporated booster, and at least one emulsion layer or hydrophilic colloid layer containing a nucleator compound comprising a hydrazin compound or a derivative thereof in an amount effective to act as a nucleator. PA0PoI3kU'D\3'O9CCLM. IVlII8
34. The method of claim 28, wherein said developer composition does not contain an alkanolamine. A method of developing an image-wise exposed silver halide photographic material containing a silver halide emulsion with a hydrazine compound as a nucleator comprising developing said silver halide photographic material with a non-hydroquinone developing composition which does not contain an alkanolamine in a concentration above 5.0 g/9, comprising: a developer selected from the group consisting of ascorbic acid, sugar-type derivatives 10 of ascorbic acid, alklui metal salts of ascorbic acid and mixtures thereof, in an amount of 0.14 to 0.28 mol/9; an effective amount of an auxiliary developing agent comprising a 3-pyrazolidone compound, an aminophenol or a mixture thereof; an alkali metal sulfite in an amount less than or equal to 0.32 mol/; 15 an alkali metal carbonate in an amount of from 0.14 to 0.28 mol/f; an alkali metal hydroxide in an amount of from 3 to 25 g/9; a restrainer in an amount of from 0.0084 to 0.0420 mol/9; an organic antifoggant agent in an amount of 0.02 to 0.2 g/P; a sequestering or chelating agent in an amount of from 0.5 to 2 g/e; wherein the developer composition has a pH of from 10.3 to 12.5 at
36. A non-hydroquinone photographic developer composition of claim 35 wherein the composition is substantially free of dihydroxy benzene as hereinbefore defined.
37. The method of claim 35, wherein said developer is selected from the group consisting of -ascorbic acid, d-erythroascorbic acid, d-gluco-ascorbic acid, 6-deoxy-g-ascorbic acid, 9- rhamno-ascorbic acid, -fucoascorbic acid, d-glucohepto-ascorbic acid, sorboascorbic acid, imino-f-ascorbic acid, o4-lactoascorbic acid, maltoascorbic acid, -araboascorbic acid, 9- glucoascorbic acid, d-galactoascorbic acid, -guloascorbic acid and -alloascorbic acid. I P\OPEfIR\lDBM\0922 .CIA- 12/1/98 -41-
38. The method of claim 35, wherein said developer comprises an alkali metal salt of ascorbic acid.
39. The method of claim 35, wherein said restrainer comprises sodium bromide; said organic anti-fogging agent comprises a mixture of benzotriazole and mercaptotetrazole; and said sequestering agent comprises NaEDTA. The method of claim 35, wherein said silver halide photographic material includes at least one emulsion layer or hydrophilic colloid layer comprises an amino compound in an 10 amount effective to act as an incorporated booster, and at least one emulsion layer or hydrophilic colloid layer containing a nucleator compound comprises a hydrazine compound *0 or a derivative thereof in an amount effective to act as a nucleator. o
41. The method of claim 35, wherein said developer composition does not contain an 15 alkanolamine.
42. The compositions of claim 1 or claim 6 and the methods of anyone of claims 12, 18, 24, 28 or 35, substantially as herein before described with reference to the Examples and Drawings. DATED this NINTH day of JANUARY 1998 Fuji Hunt Photographic Chemicals, Inc by its Patent Attorneys DAVIES COLLISON CAVE 0N OA/U 0-
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7802493A | 1993-06-18 | 1993-06-18 | |
US078024 | 1993-06-18 | ||
PCT/US1994/006353 WO1995000881A1 (en) | 1993-06-18 | 1994-06-10 | Non-hydroquinone photographic developer composition and processing method |
Publications (3)
Publication Number | Publication Date |
---|---|
AU1092295A AU1092295A (en) | 1995-01-17 |
AU689168B2 true AU689168B2 (en) | 1998-03-26 |
AU689168C AU689168C (en) | 2001-11-22 |
Family
ID=22141455
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU10922/95A Ceased AU689168C (en) | 1993-06-18 | 1994-06-10 | Non-hydroquinone photographic developer composition and processing method |
Country Status (10)
Country | Link |
---|---|
US (1) | USH2048H1 (en) |
EP (1) | EP0738400B1 (en) |
JP (1) | JPH09500221A (en) |
CN (1) | CN1053970C (en) |
AT (1) | ATE199461T1 (en) |
AU (1) | AU689168C (en) |
DE (1) | DE69426780T2 (en) |
MY (1) | MY111751A (en) |
SG (1) | SG34338A1 (en) |
WO (1) | WO1995000881A1 (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6379877B1 (en) | 1995-02-21 | 2002-04-30 | Agfa-Gevaert | Method for developing an exposed photographic silver halide material |
EP0732619A1 (en) * | 1995-02-21 | 1996-09-18 | Agfa-Gevaert N.V. | Developing method and method for developing an exposed photographic silver halide material |
US5942379A (en) * | 1995-08-10 | 1999-08-24 | Eastman Kodak Company | 3-pyrazolidone compounds and photographic developer solutions containing same |
US5589323A (en) * | 1996-01-23 | 1996-12-31 | Sun Chemical Corporation | Chemically stable ascorbate-based photographic developer and imaging process |
US5702875A (en) * | 1996-06-28 | 1997-12-30 | Eastman Kodak Company | Weakly alkaline ascorbic acid developing composition, processing kit and method using same |
US5866309A (en) * | 1997-10-22 | 1999-02-02 | Fitterman; Alan S. | Method for processing roomlight handleable photographic elements |
US5871890A (en) * | 1997-11-14 | 1999-02-16 | Eastman Kodak Company | Method for processing roomlight handleable radiographic films using two-stage development |
US5932398A (en) * | 1997-11-14 | 1999-08-03 | Eastman Kodak Company | Kit for roomlight processing of black-and-white photographic elements |
ES2224757B1 (en) * | 1998-10-13 | 2005-12-16 | Luis Casademunt Garre | PHOTO REVIEWER FOR THE PROGRESS OF EFFECTIVE SENSITIVITY IN FILMS WITH WHITE AND BLACK EMULSION. |
US6277290B1 (en) | 1999-12-17 | 2001-08-21 | Metafix Inc. | Process for recovering silver from photographic solutions |
CN102591133A (en) * | 2012-03-03 | 2012-07-18 | 合肥通用无损检测技术有限责任公司 | Developing solution and preparation method thereof |
CN103343068A (en) * | 2013-06-18 | 2013-10-09 | 厦门市豪尔新材料有限公司 | Glue stripping agent |
CN104765244A (en) * | 2015-04-30 | 2015-07-08 | 石家庄太行科工有限公司 | Environment-friendly type developing solution and preparation method and application thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4988604A (en) * | 1990-05-24 | 1991-01-29 | Eastman Kodak Company | High contrast photographic element including an aryl sulfonamidophenyl hydrazide containing both thio and ethyleneoxy groups |
WO1993011456A1 (en) * | 1991-12-02 | 1993-06-10 | E.I. Du Pont De Nemours And Company | Improved developer systems for hydrazine containing films |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE530885A (en) | 1953-08-03 | |||
US4269929A (en) | 1980-01-14 | 1981-05-26 | Eastman Kodak Company | High contrast development of photographic elements |
US4740453A (en) * | 1984-12-27 | 1988-04-26 | Fuji Photo Film Co., Ltd. | Silver halide photosensitive material containing a compound capable of releasing a photographically useful group |
JPS61233734A (en) | 1985-04-09 | 1986-10-18 | Fuji Photo Film Co Ltd | Silver halide photographic sensitive material and formation of image by using it |
JPS61267759A (en) | 1985-05-22 | 1986-11-27 | Fuji Photo Film Co Ltd | Formation of negative image |
US4975354A (en) | 1988-10-11 | 1990-12-04 | Eastman Kodak Company | Photographic element comprising an ethyleneoxy-substituted amino compound and process adapted to provide high constrast development |
EP0498968B1 (en) | 1991-02-14 | 1996-05-22 | Agfa-Gevaert N.V. | Photographic developing process utilizing an ascorbic acid derivative |
EP0501546A1 (en) | 1991-02-26 | 1992-09-02 | Agfa-Gevaert N.V. | High contrast developer containing an aprotic solvent |
EP0531582B1 (en) | 1991-09-12 | 1997-01-15 | Agfa-Gevaert N.V. | Stabilized ascorbic acid developer |
US5236816A (en) | 1992-04-10 | 1993-08-17 | Eastman Kodak Company | Photographic developing solution and use thereof in the high contrast development of nucleated photographic elements |
GB9226488D0 (en) | 1992-12-19 | 1993-02-17 | Ilford Ltd | Photographic developing solution |
US5503966A (en) | 1994-07-22 | 1996-04-02 | International Paper Company | Photographic developing compositions and use thereof in the processing of photographic elements |
-
1994
- 1994-06-10 EP EP94919380A patent/EP0738400B1/en not_active Expired - Lifetime
- 1994-06-10 JP JP7502861A patent/JPH09500221A/en active Pending
- 1994-06-10 CN CN94193074A patent/CN1053970C/en not_active Expired - Fee Related
- 1994-06-10 AU AU10922/95A patent/AU689168C/en not_active Ceased
- 1994-06-10 DE DE69426780T patent/DE69426780T2/en not_active Expired - Lifetime
- 1994-06-10 WO PCT/US1994/006353 patent/WO1995000881A1/en active IP Right Grant
- 1994-06-10 SG SG1995002196A patent/SG34338A1/en unknown
- 1994-06-10 AT AT94919380T patent/ATE199461T1/en not_active IP Right Cessation
- 1994-06-16 MY MYPI94001548A patent/MY111751A/en unknown
-
1995
- 1995-02-14 US US08/388,600 patent/USH2048H1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4988604A (en) * | 1990-05-24 | 1991-01-29 | Eastman Kodak Company | High contrast photographic element including an aryl sulfonamidophenyl hydrazide containing both thio and ethyleneoxy groups |
WO1993011456A1 (en) * | 1991-12-02 | 1993-06-10 | E.I. Du Pont De Nemours And Company | Improved developer systems for hydrazine containing films |
Also Published As
Publication number | Publication date |
---|---|
EP0738400B1 (en) | 2001-02-28 |
EP0738400A4 (en) | 1996-06-18 |
USH2048H1 (en) | 2002-09-03 |
AU1092295A (en) | 1995-01-17 |
DE69426780D1 (en) | 2001-04-05 |
CN1129989A (en) | 1996-08-28 |
CN1053970C (en) | 2000-06-28 |
ATE199461T1 (en) | 2001-03-15 |
SG34338A1 (en) | 2000-12-19 |
AU689168C (en) | 2001-11-22 |
JPH09500221A (en) | 1997-01-07 |
MY111751A (en) | 2000-12-30 |
EP0738400A1 (en) | 1996-10-23 |
WO1995000881A1 (en) | 1995-01-05 |
DE69426780T2 (en) | 2001-10-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5098819A (en) | Non-toxic photographic developer composition | |
AU689168B2 (en) | Non-hydroquinone photographic developer composition and processing method | |
EP0724193B1 (en) | Radiographic film developers containing ascorbic acid and thioether development accelerators | |
US4172728A (en) | High contrast continuous tone developer and process of use | |
EP0622671B1 (en) | Solid developing composition for silver halide photographic light-sensitive material and processing method using the same | |
US4022621A (en) | Photographic developer composition | |
US3512981A (en) | Stable photographic developers containing ascorbic acid | |
US5683859A (en) | Photographic developing composition containing a sludge inhibiting agent and use thereof in the high contrast development of nucleated photographic elements | |
US5738979A (en) | Black-and-white development processing method with replenishment | |
US5702875A (en) | Weakly alkaline ascorbic acid developing composition, processing kit and method using same | |
US5147767A (en) | Gluconic acid-based developer composition | |
US5389502A (en) | Hardening developer for silver halide photography and development method | |
EP0772799B1 (en) | Photographic developing composition and its application | |
JP3249521B2 (en) | Stabilization of photographic developer | |
US5830626A (en) | Photographic developing composition containing anti-sludging agent and use thereof | |
EP0969317B1 (en) | Method of processing a photographic high contrast silver halide material | |
EP0786698B1 (en) | Organic/inorganic developer composition | |
US3776731A (en) | Developer for photographic negatives used for printing | |
EP0969317A9 (en) | Method of processing a photographic high contrast silver halide material | |
EP0446457A2 (en) | Alkaline black-and-white photographic developer | |
EP0654148B1 (en) | Use of ketogluconates in photography | |
JP3356616B2 (en) | Method for developing silver halide photosensitive material | |
CA2064934A1 (en) | Alkaline black-and-white developer for silver halide photographic material | |
JPH06230525A (en) | Development processing method for black-and-white silver halide photographic sensitive material | |
JPH11305394A (en) | Developing method of silver halide photosensitive material |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
DA3 | Amendments made section 104 |
Free format text: THE NATURE OF THE AMENDMENT IS AS WAS NOTIFIED IN THE OFFICIAL JOURNAL DATED 19990107 |
|
MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |